ANGO · Angiodynamics Inc
$15.85
+0.19 (+1.21%)
At close · Aug 14
Market Cap
$655.12M
Shares
41.33M
Angiodynamics Inc Earnings Call Transcripts
Every quarterly earnings call for Angiodynamics Inc (ANGO) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲3.9%
$73.97M
−$4.96M
'22 Q3
22-04-07
▲13.2%
$87.00M
−$13.00M
'22 Q4
22-07-12
▲9.1%
$85.43M
−$8.49M
'23 Q2
23-01-05
▲9.1%
$80.71M
−$9.48M
'23 Q3
23-03-30
▲4.7%
$91.07M
−$21.47M
'23 Q4
23-07-12
▼3.5%
$78.68M
$45.88M
'24 Q1
23-10-04
▼7.4%
$79.07M
−$29.05M
'24 Q2
24-01-05
▼6.9%
$75.18M
−$187.74M
'24 Q3
24-04-04
▼14.2%
$67.49M
−$12.80M
'25 Q1
24-10-03
▼7.9%
$72.84M
−$10.74M
'25 Q2
25-01-08
▼4.2%
$72.00M
−$4.41M
'25 Q3
25-04-02
▲12.9%
$80.16M
−$6.05M
'25 Q4
25-07-15
▲12.2%
$75.71M
−$10.90M
'26 Q1
25-10-02
▲9%
$79.43M
−$6.35M
'26 Q2
26-01-06
▲8.9%
$78.42M
−$8.08M
'26 Q3
26-04-02
LATEST
▲8%
$86.61M
−$11.40M
'26 Q4
26-07-14
Conference
Investor event
2026-08-11
Canaccord Genuity's 46th Annual Growth Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q4
2026-07-14
Angiodynamics Inc Q4 FY2026 Earnings Call
Confident tone
MedTech growth and portfolio transformation
Mechanical thrombectomy (AlphaVac, AngioVac)
NanoKnife prostate growth and reimbursement
Revenue
$86.61M*
▲ 8% YoY Gross margin
54.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Conference
Investor event
2026-06-10
Goldman Sachs 47th Annual Global Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-04-14
25th Annual Needham Virtual Healthcare Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q3
2026-04-02
Angiodynamics Inc Q3 FY2026 Earnings Call
Confident tone
Mechanical thrombectomy (Alphavac/AngioVac)
NanoKnife and CPT-1 reimbursement
Sterilization shutdown supply-chain headwind
Revenue
$78.42M
▲ 8.9% YoY Diluted EPS
$-0.19
Gross margin
52.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q2
2026-01-06
Angiodynamics Inc Q2 FY2026 Earnings Call
Confident tone
Mechanical thrombectomy platform
Auryon growth and international expansion
NanoKnife prostate opportunity and CPT code
Revenue
$79.43M
▲ 9% YoY Diluted EPS
$-0.15
Gross margin
56.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY26 · Q1
2025-10-02
Angiodynamics Inc Q1 FY2026 Earnings Call
Confident tone
Med Tech segment growth and acceleration
Mechanical Thrombectomy (AlphaVac / AngioVac)
NanoKnife prostate indication and reimbursement
Revenue
$75.71M
▲ 12.2% YoY Diluted EPS
$-0.26
Gross margin
55.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2025-07-15
Angiodynamics Inc Q4 FY2025 Earnings Call
Confident tone
MedTech Portfolio Growth
Mechanical Thrombectomy (AlphaVac / AngioVac)
Auryon Peripheral Atherectomy
Revenue
$80.16M*
▲ 12.9% YoY Gross margin
52.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-04-02
Angiodynamics Inc Q3 FY2025 Earnings Call
Revenue
$72.00M
▼ 4.2% YoY Diluted EPS
$-0.11
Gross margin
54.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-01-08
Angiodynamics Inc Q2 FY2025 Earnings Call
Confident tone
Mechanical thrombectomy (AlphaVac and AngioVac)
NanoKnife prostate program
Guidance and profitability outlook
Revenue
$72.84M
▼ 7.9% YoY Diluted EPS
$-0.26
Gross margin
54.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2024-10-03
Angiodynamics Inc Q1 FY2025 Earnings Call
Revenue
$67.49M
▼ 14.2% YoY Diluted EPS
$-0.31
▼ 127% YoY Gross margin
54.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q3
2024-04-04
Angiodynamics Inc Q3 FY2024 Earnings Call
Revenue
$75.18M
▼ 6.9% YoY Diluted EPS
$-4.67
Gross margin
47.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-01-05
Angiodynamics Inc Q2 FY2024 Earnings Call
Balanced tone
Mechanical Thrombectomy (AngioVac / AlphaVac)
International Business
Auryon Platform
Revenue
$79.07M
▼ 7.4% YoY Diluted EPS
$-0.72
Gross margin
50.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2023-10-04
Angiodynamics Inc Q1 FY2024 Earnings Call
Revenue
$78.68M
▼ 3.5% YoY Diluted EPS
$1.15
Gross margin
50.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2023-07-12
Angiodynamics Inc Q4 FY2023 Earnings Call
Revenue
$91.07M*
▲ 4.7% YoY Gross margin
50.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-03-30
Angiodynamics Inc Q3 FY2023 Earnings Call
Revenue
$80.71M
▲ 9.1% YoY Diluted EPS
$-0.24
Gross margin
50.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-01-05
Angiodynamics Inc Q2 FY2023 Earnings Call
Revenue
$85.43M
▲ 9.1% YoY Diluted EPS
$-0.21
Gross margin
52.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2022-07-12
Angiodynamics Inc Q4 FY2022 Earnings Call
Revenue
$87.00M*
▲ 13.2% YoY Gross margin
53.4%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-04-07
Angiodynamics Inc Q3 FY2022 Earnings Call
Revenue
$73.97M
▲ 3.9% YoY Diluted EPS
$-0.13
Gross margin
52.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-01-06
Angiodynamics Inc Q2 FY2022 Earnings Call
Revenue
$78.28M
▲ 7.6% YoY Diluted EPS
$-0.21
Gross margin
51.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2021-09-30
Angiodynamics Inc Q1 FY2022 Earnings Call
Revenue
$76.97M
▲ 9.6% YoY Diluted EPS
$-0.18
Gross margin
52.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2021-07-13
Angiodynamics Inc Q4 FY2021 Earnings Call
Revenue
$76.84M*
▲ 31.7% YoY Gross margin
55.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-03-30
Angiodynamics Inc Q3 FY2021 Earnings Call
Revenue
$71.18M
▲ 2% YoY Diluted EPS
$-0.09
Gross margin
54.1%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-01-07
Angiodynamics Inc Q2 FY2021 Earnings Call
Revenue
$72.77M
▲ 4% YoY Diluted EPS
$-0.11
Gross margin
55.2%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2020-09-29
Angiodynamics Inc Q1 FY2021 Earnings Call
Revenue
$70.22M
▲ 6.3% YoY Diluted EPS
$-0.11
Gross margin
50.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-07-16
Angiodynamics Inc Q4 FY2020 Earnings Call
Revenue
$58.33M
▼ 18.1% YoY Diluted EPS
$-4.14
▼ 368.8% YoY Gross margin
51.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-04-07
Angiodynamics Inc Q3 FY2020 Earnings Call
Revenue
$69.78M
▲ 6.5% YoY Diluted EPS
$-0.15
▼ 850% YoY Gross margin
57.8%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-01-07
Angiodynamics Inc Q2 FY2020 Earnings Call
Revenue
$70.00M
▲ 0% YoY Diluted EPS
$-0.07
▼ 216.7% YoY Gross margin
59.3%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2019-08-31
Angiodynamics Inc Q1 FY2020 Earnings Call
Revenue
$66.04M
▲ 3.3% YoY Diluted EPS
$-0.03
Gross margin
57.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Showing 1–29 of 29 earnings calls
Key facts
CIK
1275187
CUSIP
03475V101
13F (30d)
150 filings
150 filers
Visit website
Investor relations